Molecular Typing of Candida glabrata

The yeast Candida glabrata has emerged, second only to Candida albicans , to be one of the most frequently isolated fungi in clinical specimen from human. Its frequent resistance towards azole antifungal drugs and the high capacity to form biofilms on indwelling catheters of individual isolates rend...

Full description

Saved in:
Bibliographic Details
Published inMycopathologia (1975) Vol. 185; no. 5; pp. 755 - 764
Main Authors Gabaldón, Toni, Gómez-Molero, Emilia, Bader, Oliver
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.10.2020
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The yeast Candida glabrata has emerged, second only to Candida albicans , to be one of the most frequently isolated fungi in clinical specimen from human. Its frequent resistance towards azole antifungal drugs and the high capacity to form biofilms on indwelling catheters of individual isolates render it an often difficult to treat pathogen. Hence, there is a notably increasing scientific and clinical interest in this species. This has led to the development of a variety of molecular tools for genetic modification, strain collections, and last but not least different approaches to analyse the population structure among isolates of different geographical and clinical contexts. Often, these are used to study correlations (or the absence thereof) with different pathogenicity, virulence, or drug resistance traits. Three molecular methods have been used to type within the C. glabrata population on a genetic level by multiple studies: multi-locus sequence typing, microsatellite length polymorphisms, and clustering of whole-genome sequencing data, and these are subject of this review.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0301-486X
1573-0832
1573-0832
DOI:10.1007/s11046-019-00388-x